Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.7300
- TODAY'S CHANGE (%)-0.2500 (-5.0201%)
- Bid / Lots4.7000/ 5
- Ask / Lots4.8300/ 1
- Open / Previous Close5.0400 / 4.9800
- Day Range
- 52 Week Range
- Volume511,070
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 37061 | 5.007 |
| 09:34 ET | 6702 | 4.93 |
| 09:38 ET | 3023 | 4.9016 |
| 09:39 ET | 702 | 4.9 |
| 09:41 ET | 1758 | 4.852 |
| 09:43 ET | 12735 | 4.8518 |
| 09:45 ET | 460 | 4.8424 |
| 09:48 ET | 3160 | 4.8101 |
| 09:50 ET | 3092 | 4.81 |
| 09:52 ET | 1968 | 4.805 |
| 09:54 ET | 1920 | 4.845 |
| 09:56 ET | 830 | 4.885 |
| 09:57 ET | 652 | 4.83 |
| 09:59 ET | 200 | 4.86 |
| 10:01 ET | 1313 | 4.88 |
| 10:03 ET | 1718 | 4.94 |
| 10:06 ET | 900 | 4.93 |
| 10:08 ET | 870 | 4.9 |
| 10:10 ET | 638 | 4.8717 |
| 10:12 ET | 2541 | 4.84 |
| 10:14 ET | 400 | 4.81 |
| 10:15 ET | 962 | 4.79 |
| 10:17 ET | 238 | 4.7917 |
| 10:19 ET | 3917 | 4.79 |
| 10:21 ET | 1100 | 4.8 |
| 10:24 ET | 1667 | 4.8 |
| 10:26 ET | 1627 | 4.82 |
| 10:32 ET | 1641 | 4.847 |
| 10:35 ET | 256 | 4.8582 |
| 10:37 ET | 100 | 4.86 |
| 10:39 ET | 5475 | 4.81 |
| 10:42 ET | 518 | 4.81 |
| 10:44 ET | 2529 | 4.82 |
| 10:46 ET | 619 | 4.84 |
| 10:48 ET | 100 | 4.85 |
| 10:50 ET | 500 | 4.82 |
| 10:51 ET | 647 | 4.81 |
| 10:53 ET | 300 | 4.79 |
| 10:55 ET | 1000 | 4.8 |
| 11:00 ET | 200 | 4.8 |
| 11:02 ET | 100 | 4.79 |
| 11:04 ET | 2398 | 4.79 |
| 11:06 ET | 2554 | 4.765 |
| 11:08 ET | 1503 | 4.7533 |
| 11:09 ET | 1603 | 4.79 |
| 11:11 ET | 100 | 4.795 |
| 11:13 ET | 100 | 4.795 |
| 11:15 ET | 100 | 4.795 |
| 11:18 ET | 100 | 4.795 |
| 11:24 ET | 200 | 4.78 |
| 11:27 ET | 100 | 4.8 |
| 11:29 ET | 3537 | 4.7659 |
| 11:31 ET | 2330 | 4.77 |
| 11:33 ET | 446 | 4.7617 |
| 11:36 ET | 1511 | 4.75 |
| 11:38 ET | 5378 | 4.79 |
| 11:40 ET | 2253 | 4.78 |
| 11:42 ET | 5938 | 4.78 |
| 11:44 ET | 980 | 4.77 |
| 11:45 ET | 1764 | 4.77 |
| 11:47 ET | 1300 | 4.75 |
| 11:49 ET | 450 | 4.7417 |
| 11:51 ET | 3175 | 4.775 |
| 11:54 ET | 2840 | 4.76 |
| 11:56 ET | 100 | 4.76 |
| 11:58 ET | 3000 | 4.76 |
| 12:00 ET | 100 | 4.76 |
| 12:02 ET | 645 | 4.76 |
| 12:03 ET | 304 | 4.76 |
| 12:05 ET | 9800 | 4.78 |
| 12:07 ET | 1936 | 4.77 |
| 12:09 ET | 1800 | 4.77 |
| 12:12 ET | 404 | 4.77 |
| 12:14 ET | 300 | 4.77 |
| 12:16 ET | 759 | 4.765 |
| 12:18 ET | 100 | 4.765 |
| 12:20 ET | 1656 | 4.7883 |
| 12:21 ET | 300 | 4.77 |
| 12:23 ET | 750 | 4.75 |
| 12:25 ET | 300 | 4.75 |
| 12:27 ET | 200 | 4.75 |
| 12:30 ET | 300 | 4.76 |
| 12:32 ET | 800 | 4.765 |
| 12:36 ET | 2544 | 4.7689 |
| 12:38 ET | 445 | 4.77 |
| 12:39 ET | 100 | 4.765 |
| 12:41 ET | 9353 | 4.77 |
| 12:43 ET | 459 | 4.7794 |
| 12:45 ET | 1717 | 4.755 |
| 12:48 ET | 100 | 4.74 |
| 12:50 ET | 708 | 4.722 |
| 12:52 ET | 495 | 4.73 |
| 12:54 ET | 100 | 4.73 |
| 12:56 ET | 400 | 4.73 |
| 12:57 ET | 200 | 4.72 |
| 01:01 ET | 400 | 4.73 |
| 01:03 ET | 2824 | 4.72 |
| 01:06 ET | 500 | 4.72 |
| 01:08 ET | 100 | 4.72 |
| 01:10 ET | 200 | 4.71 |
| 01:12 ET | 300 | 4.715 |
| 01:15 ET | 247 | 4.7188 |
| 01:17 ET | 2694 | 4.705 |
| 01:19 ET | 733 | 4.69 |
| 01:21 ET | 921 | 4.68 |
| 01:24 ET | 104 | 4.685 |
| 01:26 ET | 858 | 4.69 |
| 01:28 ET | 600 | 4.69 |
| 01:30 ET | 807 | 4.715 |
| 01:32 ET | 1714 | 4.69 |
| 01:33 ET | 800 | 4.6901 |
| 01:35 ET | 100 | 4.69 |
| 01:39 ET | 640 | 4.69 |
| 01:42 ET | 403 | 4.7 |
| 01:44 ET | 310 | 4.7 |
| 01:46 ET | 614 | 4.7 |
| 01:48 ET | 200 | 4.7 |
| 01:53 ET | 100 | 4.7 |
| 01:55 ET | 1783 | 4.699 |
| 02:04 ET | 1120 | 4.6607 |
| 02:06 ET | 500 | 4.65 |
| 02:09 ET | 615 | 4.65 |
| 02:11 ET | 1092 | 4.65 |
| 02:13 ET | 3797 | 4.625 |
| 02:15 ET | 200 | 4.61 |
| 02:18 ET | 100 | 4.62 |
| 02:20 ET | 100 | 4.63 |
| 02:22 ET | 600 | 4.64 |
| 02:24 ET | 603 | 4.62 |
| 02:26 ET | 100 | 4.625 |
| 02:29 ET | 13801 | 4.68 |
| 02:31 ET | 1400 | 4.66 |
| 02:33 ET | 100 | 4.63 |
| 02:36 ET | 374 | 4.63 |
| 02:38 ET | 400 | 4.62 |
| 02:40 ET | 1100 | 4.62 |
| 02:42 ET | 6127 | 4.645 |
| 02:44 ET | 1000 | 4.63 |
| 02:45 ET | 100 | 4.63 |
| 02:47 ET | 509 | 4.63 |
| 02:49 ET | 1008 | 4.64 |
| 02:51 ET | 2912 | 4.6517 |
| 02:56 ET | 703 | 4.67 |
| 02:58 ET | 3444 | 4.66 |
| 03:00 ET | 203 | 4.665 |
| 03:03 ET | 2376 | 4.65 |
| 03:05 ET | 100 | 4.635 |
| 03:07 ET | 2596 | 4.655 |
| 03:09 ET | 2412 | 4.67 |
| 03:12 ET | 300 | 4.66 |
| 03:18 ET | 350 | 4.6605 |
| 03:21 ET | 1619 | 4.6799 |
| 03:23 ET | 200 | 4.6712 |
| 03:25 ET | 400 | 4.675 |
| 03:30 ET | 100 | 4.675 |
| 03:32 ET | 900 | 4.675 |
| 03:34 ET | 1992 | 4.6775 |
| 03:36 ET | 300 | 4.67 |
| 03:38 ET | 2504 | 4.675 |
| 03:39 ET | 1315 | 4.685 |
| 03:41 ET | 6266 | 4.68 |
| 03:43 ET | 332 | 4.685 |
| 03:45 ET | 9148 | 4.715 |
| 03:48 ET | 824 | 4.715 |
| 03:50 ET | 9903 | 4.725 |
| 03:52 ET | 2500 | 4.725 |
| 03:54 ET | 10713 | 4.74 |
| 03:56 ET | 6098 | 4.735 |
| 03:57 ET | 7054 | 4.73 |
| 03:59 ET | 109177 | 4.73 |
May 17, 2024
May 16, 2024
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences, from 4:05PM ET on Thursday May 16, 2024 by Dow Jones
4:05PM ET on Thursday May 16, 2024 by Dow JonesVentyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer, from 8:00AM ET on Thursday May 16, 2024 by Dow Jones
8:00AM ET on Thursday May 16, 2024 by Dow JonesPress Release: Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer, from 8:00AM ET on Thursday May 16, 2024 by Dow Jones
8:00AM ET on Thursday May 16, 2024 by Dow Jones
May 14, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 333.5M | -1.5x | --- |
Alto Neuroscience Inc | 335.2M | -6.6x | --- |
Skye Bioscience Inc | 338.2M | -2.7x | --- |
Fractyl Health Inc | 338.0M | -4.1x | --- |
Erasca Inc | 341.5M | -2.3x | --- |
Candel Therapeutics Inc | 342.1M | -8.9x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Operating Officer
- Matthew Moore
- Chief Scientific Officer
- John Nuss
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $333.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
